CAS: 732278-52-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (R)-5-(4-Amino-3-methyl-phenyl)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-1,3-dioxolo[4,5-H][2,3]-benzodiazepine REF: 3D-HEB27852CAS: 732278-52-3 | Min. 95% | To inquire | Mon 13 Jan 25 |
 | BDZ-g REF: TM-T62042CAS: 732278-52-3 | 98.77% | 113.00 €~1,052.00 € | Mon 03 Mar 25 |
(R)-5-(4-Amino-3-methyl-phenyl)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-1,3-dioxolo[4,5-H][2,3]-benzodiazepine
CAS:732278-52-3
Please enquire for more information about (R)-5-(4-Amino-3-methyl-phenyl)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-1,3-dioxolo[4,5-H][2,3]-benzodiazepine including the price, delivery time and more detailed …
Formula:
C21H21N5O2S
Purity:
Min. 95%
Molecular weight:
407.5 g/mol
Ref: 3D-HEB27852
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
BDZ-g
CAS:732278-52-3
BDZ-g: potent, selective AMPA receptor antagonist; useful for researching neurological disorders.
Formula:
C21H21N5O2S
Purity:
98.77%
Color and Shape:
Solid
Molecular weight:
407.49
Ref: TM-T62042
| 1mg | 113.00 € | ||
| 5mg | 250.00 € | ||
| 10mg | 367.00 € | ||
| 25mg | 551.00 € | ||
| 50mg | 771.00 € | ||
| 100mg | 1,052.00 € | ||
| 1mL*10mM (DMSO) | 276.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
